For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
21
views
7
references
 Top references
cited by
3
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      389
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Homocystinuria with Cerebral Venous Sinus Thrombosis: Excellent Recovery with Intravenous Recombinant Tissue Plasminogen Activator

      case-report

      Read this article at

      ScienceOpenPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hyperhomocysteinemia can cause cerebral venous thrombosis. Recombinant tissue plasminogen activator is one of the treatment options for cerebral venous thrombosis in selected cases. We present here a 7-year-old boy with homocysteinuria with stroke. MRI of brain showed cerebral venous sinus thrombosis. We successfully treated with intravenous recombinant tissue plasminogen activator. He recovered completely without any complications.

          Recombinant tissue plasminogen activator can be considered one of the treatment options in cerebral venous thrombosis in homocystinura.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: found
          • Article: not found

          Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.

          R Golomb, Amy Jones, F Kirkham … (2008)
          The purpose of this statement is to review the literature on childhood stroke and to provide recommendations for optimal diagnosis and treatment. This statement is intended for physicians who are responsible for diagnosing and treating infants, children, and adolescents with cerebrovascular disease. The Writing Group members were appointed by the American Heart Association Stroke Council's Scientific Statement Oversight Committee. The panel included members with several different areas of expertise. Each of the panel's recommendations was weighted by applying the American Heart Association Stroke Council's Levels of Evidence grading algorithm. After being reviewed by panel members, the manuscript was reviewed by 4 expert peer reviewers and by members of the Stroke Council Leadership Committee and was approved by the American Heart Association Science Advisory and Coordinating Committee. We anticipate that this statement will need to be updated in 4 years. Evidence-based recommendations are provided for the prevention of ischemic stroke caused by sickle cell disease, moyamoya disease, cervicocephalic arterial dissection, and cardiogenic embolism. Recommendations on the evaluation and management of hemorrhagic stroke also are provided. Protocols for dosing of heparin and warfarin in children are suggested. Also included are recommendations on the evaluation and management of perinatal stroke and cerebral sinovenous thrombosis in children.
          Article 0 comments Cited 144 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders.

            Philip Gorelick, Fernando Testai (2010)
            Several inherited metabolic disorders have been associated with stroke particularly in newborns, children, and young adults. In part 1, we discussed the genetics, stroke pathophysiology, clinical presentation, diagnosis, and treatment of Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. In part 2, we overview homocystinuria, organic acidurias, and urea cycle disorders.
            Article 0 comments Cited 23 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Thrombolysis for ischemic stroke in children: data from the nationwide inpatient sample.

              N Janjua, Adnan Qureshi, J. Lynch … (2007)
              Few pediatric reports of thrombolysis exist. We sought to determine national rates of thrombolysis among pediatric ischemic stroke patients using a national database. Patients between the ages of 1 and 17 years, entered in the Nationwide Inpatient Sample between 2000 and 2003, with International Classification of Diseases codes for ischemic stroke were included in the study. Differences in mean age, gender distribution, ethnicity, secondary diagnoses, medical complications, associated procedure rates, modes of discharge, and hospital costs between pediatric stroke patients receiving and not receiving thrombolysis were estimated. In the United States, between 2000 and 2003 an estimated 2904 children were admitted with ischemic stroke, of which 46 children (1.6%) received thrombolytic therapy. Children who received thrombolysis were on the average older (11 versus 9 years), more likely to be male (100% versus 53.8%), with significantly higher hospital costs ($81,800 versus $38,700). These children were also less likely to be discharged home with higher rates of death and dependency, although differences in clinical severity between the 2 groups was not known. Thrombolysis, though not indicated for patients <18 years of age, is currently being administered to children, with unclear benefit. Larger studies are needed to evaluate the safety and efficacy of this treatment for children.
              Article 0 comments Cited 19 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Journal
                Journal ID (nlm-ta): Iran J Child Neurol
                Journal ID (iso-abbrev): Iran J Child Neurol
                Journal ID (publisher-id): IJCN
                Title: Iranian Journal of Child Neurology
                Publisher: Shahid Beheshti University of Medical Sciences (Tehran, Iran )
                ISSN (Print): 1735-4668
                ISSN (Electronic): 2008-0700
                Publication date (Print): Summer 2017
                Volume: 11
                Issue: 3
                Pages: 48-52
                Affiliations
                [1 ]Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bangalore, Karnataka, India
                [2 ]Department of Pediatric Intescivie, Sagar Hospital, Jayanagar, Bangalore, India
                [3 ]Department of Neuroradiology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India
                [4 ]Department of Pediatrics, Indira Gandhi Institute of Child Health, Bangalore, Karnataka, India
                Author notes
                Corresponding Author: Gowda VK. MD, Bangalore Child Neurology and Rehabilitation Center, No 8/A, First Cross, First Main, Near Adhichunchanagiri choultry, Vijayanagar, Bangalore-560104, Phone No: +91 9535212556, Email:drknvraju@hotmail.com, drknvraju@yahoo.co.in
                Article
                Publisher ID: ijcn-11-048
                PMC ID: 5582360
                PubMed ID: 28883877
                SO-VID: 34e9f3f3-cda3-4639-b0d3-63389b7fa900
                License:

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License, ( http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Date received : 11 October 2015
                Date revision received : 7 August 2016
                Date accepted : 9 August 2016
                Categories
                Subject: Case Report

                Keywords: homocystinuria,intracranial sinus thrombosis,tissue plasminogen activator
                Data availability:
                Keywords: homocystinuria, intracranial sinus thrombosis, tissue plasminogen activator

                Comments

                Comment on this article

                Similar content389

                See all similar

                Cited by3

                See all cited by

                Most referenced authors121

                See all reference authors